New Body Line stock reports a 41 percent revenue decline

New Body Line stock (ISIN TN0007540016) reported first-half 2026 revenue of TND 2.6 million, down 41 percent from TND 4.5 million a year earlier. TeraFinances published the figures on September 18, 2026, for the period ended June 30, 2026.

Export demand drives the decline

Export revenue, the companys main business channel, fell 47 percent to TND 2.3 million from TND 4.4 million in the first half of 2025. Local sales moved in the opposite direction, rising from TND 109.0 thousand to TND 329.3 thousand, but remained smaller than export activity.

African Manager reported on September 22, 2026, that operating income fell 75 percent to TND 110.8 thousand and EBITDA fell 84 percent to TND 161.0 thousand. The comparison shows that the revenue contraction reached operating profit more sharply than the headline sales decline.

Profit falls while debt stays at zero

Net income fell 71 percent to TND 169.1 thousand from TND 580.9 thousand in the first half of 2025, reducing earnings per share to TND 0.04 from TND 0.14, according to TeraFinances.

The balance sheet provides a counterpoint. Gross financial debt remained at TND 0, while net cash stood at TND 1.3 million after falling from TND 1.7 million at the end of 2025. Operating cash flow also declined 70 percent to TND 267.9 thousand, and the company initiated TND 212.5 thousand in dividend payments for the 2025 result.

Stock stays at TND 2.900

New Body Line stock last stood at TND 2.900 on the Bourse de Tunis on October 1, 2026, with a daily change of 0.00 percent. The official exchange bulletin identifies New Body Line, ticker NBL, and ISIN TN0007540016 on the main equity market on September 28, 2026, as shown by the Bourse de Tunis.

More news and analyses on New Body Line stock